Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Capsugel Launches Dosage Form Solutions Unit | Contract Pharma

What are you searching for?

Sign in
Breaking News

Capsugel Launches Dosage Form Solutions Unit

Patel to serve as president

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Capsugel has launched its Dosage Form Solutions (DFS) business unit focused on lipid-based formulations, as well as continued expansion of its targeted release capsules offerings. Amit Patel will serve as president of the DFS unit from Capsugel’s headquarters in Morristown, NJ. Mr. Patel has extensive experience in the pharmaceutical industry, including generics and specialty pharmaceuticals.
 
“With the launch of the new DFS business unit, Capsugel builds on its heritage of delivering innovative, quality products and services in hard capsules, by advancing our expertise in product formulation and commercial finished product manufacturing,” said Guido Driesen, president and chief executive officer of Capsugel. “DFS is well-positioned to help address our customers’ most pressing dosage form challenges of existing and new nutritional and pharmaceutical products.”
 
DFS has operations in North America, Europe and Asia, and serves leading and emerging specialty, branded and generic pharmaceutical customers, as well as the consumer health and nutritional segments.  
 
See our interview with Mr. Driesen in the Jan/Feb issue of Contract Pharma!  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics